Apoptosis regulator Bcl-2 — Drug Target

All drugs that target Apoptosis regulator Bcl-2 — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

BCL-2 Inhibitor [EPC] · Microtubule Inhibitor · chlorcyclizine

Marketed (3)

• Venclexta · AbbVie · BCL-2 Inhibitor [EPC] · Oncology
  Venclexta is a selective and orally bioavailable small-molecule inhibitor of BCL-2, an anti-apoptotic protein.
• Ixempra Kit · R-Pharm Us Llc · Microtubule Inhibitor · Oncology
  Ixempra Kit works by disrupting cell division, preventing cancer cells from growing and multiplying.
• Perazyl · chlorcyclizine · Infectious Disease